PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Cureus0 citationsOpen Access

Gliosarcoma: A Case Series and Comprehensive Literature Review

View Full Paper
HMHarvey Misael Aguilar MoraLRLaura Karina Barrera RomanGSGervith Reyes Soto

Key Points

  • This report aims to provide insights into the clinical and pathological characteristics of gliosarcoma through a case series.
  • Presented cases of three patients diagnosed with gliosarcoma
  • Characterized clinical symptoms and neuroimaging findings
  • Performed surgical resection followed by adjuvant therapies
  • Patients exhibited various symptoms, including headaches and seizures
  • All patients received multimodal treatment but experienced disease progression
  • Median overall survival reported as approximately 13-16 months

Abstract

Gliosarcoma represents an uncommon primary neoplasm of the central nervous system, distinguished by a biphasic histological architecture that combines glial and mesenchymal elements. In this report, we present three cases of intracranial tumors confirmed histopathologically as gliosarcoma, offering a comprehensive account of their clinical presentation, neuroimaging characteristics, and pathological features. The lesions involved different cerebral regions, specifically the frontal, temporal, and occipital lobes, and manifested with a heterogeneous range of symptoms, including headache, focal motor weakness, and epileptic seizures. The series comprises two male patients and one female patient, aged 54, 51, and 63 years. All patients underwent surgical resection, followed by adjuvant radiotherapy with concurrent and/or adjuvant temozolomide. Despite multimodal treatment, disease progression occurred, consistent with the aggressive biological behavior of gliosarcoma, which is associated with a reported median overall survival of approximately 13-16 months. Through detailed analysis of each case, we highlight the key clinical, radiological, and histopathological findings, emphasizing their diagnostic value and the importance of integrating treatment and outcome data to contextualize prognosis in this rare tumor entity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mora et al. (2026) studied this question.

synapsesocial.com/papers/69994a7f873532290d01eff9https://doi.org/10.7759/cureus.103773
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The 2021 WHO Classification of Tumors of the Central Nervous System: a summary2021 · 12,447 citations
  2. 2Primary versus secondary gliosarcoma: a systematic review and meta-analysis2022 · 8 citations
  3. 3Clinicopathologic and genomic features of gliosarcomas2012 · 60 citations
  4. 4Clinical and epidemiological characteristics of pediatric gliosarcomas2009 · 27 citations
  5. 5Primary cerebral gliosarcoma: report of 17 cases1995 · 47 citations